logo

For the Inventor, By the Inventor

Vienna, Austria

Jürgen Heindl-Wruss

This inventor holds 18 USPTO granted patents and 7 published patent applications and 1 EPO patent, primarily in Viral Vaccine Development. Top assignees: Valneva Austria Gmbh, Valneva Se, Dynavax Technologies Corporation. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jürgen Heindl-Wruss. Retrieved from https://idiyas.com/inventor/jurgen-heindl-wruss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 56(Granted Patents)


Company Filing History:

goldMedal10 out of 46 
 
Valneva Austria Gmbh
 patents
silverMedal8 out of 13 
 
Valneva Se
 patents
bronzeMedal1 out of 66 
 
Dynavax Technologies Corporation
 patents
where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Virus Purification
Zika Virus Vaccine
Chikungunya Virus
Pharmaceutical Compositions
CpG-Adjuvanted Vaccines
Immunogenic Formulations
Aluminum Compounds
Therapeutics
18 patents (USPTO):Explore Patents
1. 12214033 - Virus purification (2025-02-04),
2. 12102673 - Zika virus vaccine (2024-10-01),
3. 12011477 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3 (2024-06-18),
4. 12005111 - Zika virus vaccine (2024-06-11),
5. 11951163 - Zika virus vaccine (2024-04-09),
6. 11684669 - CpG-adjuvanted SARS-CoV-2 virus vaccine (2023-06-27),
7. 11524064 - Zika virus purification (2022-12-13),
8. 11484587 - Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3 (2022-11-01),
9. 11406700 - Virus purification (2022-08-09),
10. 11357846 - Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3 (2022-06-14),
11. 11331382 - Zika virus purification (2022-05-17),
12. 11219681 - Zika virus vaccine (2022-01-11),
13. 11207397 - Virus purification (2021-12-28),
14. 11110170 - Aluminum compounds for use in therapeutics and vaccines (2021-09-07),
15. 10668146 - Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines (2020-06-02),

Title: The Innovative Contributions of Jürgen Heindl-Wruss

Introduction

Jürgen Heindl-Wruss is a notable inventor based in Vienna, Austria. With an impressive portfolio of 16 patents, Heindl-Wruss has made significant strides in the field of biochemistry and virology.

Latest Patents

Among his latest innovations, Heindl-Wruss has developed methods for virus purification, particularly focusing on processes that purify infectious virus particles using protamine. Additionally, he has been instrumental in creating Zika virus vaccines, detailing compositions and methodologies for producing and administering these vaccines effectively to those in need.

Career Highlights

Heindl-Wruss has had a distinguished career, working with prominent organizations such as Valneva Austria GmbH and Valneva SE. His contributions within these companies have been pivotal in advancing research and development initiatives in virology.

Collaborations

Throughout his career, Heindl-Wruss has collaborated with talented colleagues, including Mario Nebenführ and Michael Weber. These partnerships have fostered a collaborative environment that underscores the importance of teamwork in scientific innovation.

Conclusion

Jürgen Heindl-Wruss is an exemplary inventor whose work continues to influence the fields of virology and vaccine development. His pioneering patents reflect his commitment to advancing healthcare solutions and highlight the critical role of innovation in addressing public health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…